Announced
Completed
Financials
Tags
United Kingdom
pharmaceuticals
Pharmaceuticals
Acquisition
Friendly
Single Bidder
Public
Private Equity
Majority
Cross Border
Completed
Synopsis
EQT, a private equity company, and ADIA, a sovereign wealth fund, completed the acquisition of Dechra Pharmaceuticals, a pharmaceutical company, for £4.88bn. "We plan to support Dechra's talented management team accelerating their business strategy and long-term growth in an increasingly competitive environment by providing, where needed, additional investment in its innovative pipeline and further supporting global expansion. We believe that private ownership will enable Dechra's management team to take a longer-term view as it focuses on accelerating growth," Anthony Santospirito, EQT Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.